4D Molecular Therapeutics (FDMT) Revenue (2020 - 2026)
4D Molecular Therapeutics (FDMT) reported Revenue of $3.78 million for Q2 2026, compared with $15,000 a year earlier and up 24.1% from the prior quarter.
Powered by 
Analysis
4D Molecular Therapeutics (FDMT) Revenue (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, 4D Molecular Therapeutics' Revenue came in at $92.01 million; for FY2025, it was $85.21 million.
- Revenue has a five-year compound annual growth rate of 44.3% (FY2020 to FY2025).
- By year, Revenue came in at $37,000 in FY2024 (-99.8%), $20.72 million in FY2023 (+562.3%), $3.13 million in FY2022 (-82.7%) and $18.04 million in FY2021 (+32.5%).
- Five-year quarterly Revenue spans a low of -$19,000 in Q4 2023 and a high of $85.09 million in Q4 2025.
- The high point for year-over-year Revenue in five years was Q2 2025 (growth of 200.0%); the low point was Q3 2024 (a decline of 100.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $3.05 million (Q1 2026), $85.09 million (Q4 2025) and $90,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.33 Bn |
| 10 | 4D Molecular Therapeutics | 1.02 Bn | -436.78 Mn | - | 3.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.78 Mn |
| Mar 31, 2026 | 3.05 Mn |
| Dec 31, 2025 | 85.09 Mn |
| Sep 30, 2025 | 90,000.00 |
| Jun 30, 2025 | 15,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Mar 31, 2024 | 28,000.00 |
| Dec 31, 2023 | -19,000.00 |
| Sep 30, 2023 | 20.20 Mn |
| Jun 30, 2023 | 239,000.00 |
| Mar 31, 2023 | 298,000.00 |
| Dec 31, 2022 | 1.25 Mn |
| Sep 30, 2022 | 500,000.00 |
| Jun 30, 2022 | 162,000.00 |
| Mar 31, 2022 | 1.22 Mn |
| Dec 31, 2021 | 92,000.00 |
| Sep 30, 2021 | 1.37 Mn |
API Access
4D Molecular Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=FDMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "FDMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=FDMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();